Critical Path Institute's (C-Path) Translational Therapeutics Accelerator (TRxA) and Celdara Medical today announced the signing of a Memorandum of Understanding (MOU) aimed at identifying and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results